Physician profile
Debra Fast
NPI 1184624496
$8,290.36
in general payments reported to CMS, 2019-2025
52 companies · $1,302 in 2025
The $1,302 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,228 · 2020: $907 · 2021: $1,114 · 2022: $1,155 · 2023: $1,373 · 2024: $1,212 · 2025: $1,302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,788 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,787.57 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,234.60 | 2019-2025 | |
| Novo Nordisk INC | $803.35 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $748.94 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $509.71 | 2019-2025 | Evenity, Prolia, Prolia |
| Pfizer INC. | $507.53 | 2019-2025 | |
| Radius Health, INC. | $441.75 | 2019-2025 | Tymlos |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $384.87 | 2019-2025 | Xifaxan |
| Astellas Pharma US INC | $333.33 | 2019-2025 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $313.22 | 2019-2025 | Ofev, Jardiance |
| Merck Sharp & Dohme LLC | $296.77 | 2019-2024 | Gardasil, Gardasil 9, Capvaxive |
| Astrazeneca Pharmaceuticals LP | $253.04 | 2019-2025 | Airsupra, Breztri |
| Amarin Pharma, INC. | $229.35 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $188.28 | 2021-2024 | |
| Xeris Pharmaceuticals, INC. | $171.85 | 2022-2025 | Gvoke Hypopen |
| Phathom Pharmaceuticals, INC. | $131.94 | 2024-2025 | Voquezna |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $106.69 | 2022-2025 | Freestyle Libre 2 |
| Exact Sciences Corporation | $96.32 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $91.78 | 2020-2023 | Hyqvia |
| Seqirus USA INC | $87.68 | 2022-2025 | Flucelvax, Fluad, Flucelvax Quadrivalent |
| Biohaven Pharmaceutical Holding Company LTD. | $80.85 | 2022 | |
| Novartis Pharmaceuticals Corporation | $78.10 | 2022-2025 | |
| Allergan, INC. | $77.22 | 2019-2022 | |
| Optinose US, INC. | $74.21 | 2024-2025 | |
| Biohaven Pharmaceuticals, INC. | $69.76 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $65.79 | 2019-2021 | |
| Merz North America, INC. | $65.02 | 2022 | |
| Glaxosmithkline, LLC. | $64.82 | 2021-2025 | Arexvy, Shingrix |
| Idorsia Pharmaceuticals US INC | $60.10 | 2022-2023 | Quviviq |
| Teva Pharmaceuticals USA, INC. | $58.14 | 2019-2021 | |
| Corcept Therapeutics | $54.92 | 2023 | Korlym |
| Sanofi-Aventis U.S. LLC | $52.82 | 2020-2021 | |
| Amneal Pharmaceuticals LLC | $50.18 | 2023-2025 | Unithroid |
| Alfasigma USA, INC. | $47.26 | 2021-2022 | |
| Dynavax Technologies Corporation | $43.23 | 2023 | Heplisav-B |
| Zimmer Biomet Holdings, INC. | $39.45 | 2019 | |
| Biogen, INC. | $37.22 | 2021 | |
| Medtronic, INC. | $36.61 | 2022-2023 | Intellis Adaptivestim |
| Axsome Therapeutics, INC. | $36.30 | 2024 | Auvelity |
| Esperion Therapeutics, INC. | $33.61 | 2022-2023 | Nexletol |
| Vbi Vaccine (Delaware) INC. | $26.22 | 2023 | Prehevbrio |
| E.R. Squibb & Sons, L.L.C. | $25.60 | 2019-2024 | Eliquis |
| Madrigal Pharmaceuticals | $22.64 | 2025 | Rezdiffra |
| Janssen Pharmaceuticals, INC | $21.89 | 2023 | Spravato |
| Hologic Sales and Service, LLC | $18.98 | 2024 | Aptima |
| Pulmonx Corporation | $18.55 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Mannkind Corporation | $17.12 | 2019 | |
| Jazz Pharmaceuticals INC. | $16.85 | 2021 | |
| Baxter Healthcare | $15.89 | 2022 | |
| Horizon Therapeutics Plc | $13.62 | 2021 | |
| Bardy Diagnostics, INC. | $13.00 | 2022 | |
| Avanir Pharmaceuticals, INC. | $11.89 | 2020 | |
| Therapeuticsmd, INC. | $11.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Fast listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.